Review Article | Published:

Pathophysiology of T follicular helper cells in humans and mice

Nature Immunology volume 16, pages 142152 (2015) | Download Citation

Abstract

Follicular helper T cells (TFH cells) compose a heterogeneous subset of CD4+ T cells that induce the differentiation of B cells into plasma cells and memory cells. They are found within and in proximity to germinal centers in secondary lymphoid organs, and their memory compartment also circulates in the blood. Our knowledge on the biology of TFH cells has increased significantly during the past decade, largely as a result of mouse studies. However, recent studies on human TFH cells isolated from lymphoid organ and blood samples and recent observations on the developmental mechanism of human TFH cells have revealed both similarities and differences between human and mouse TFH cells. Here we present the similarities and differences between mouse and human lymphoid organ–resident TFH cells and discuss the role of TFH cells in response to vaccines and in disease pathogenesis.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & Cell to cell interaction in the immune response. I. Hemolysin-forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes. J. Exp. Med. 128, 801–820 (1968).

  2. 2.

    Germinal centers. Annu. Rev. Immunol. 12, 117–139 (1994).

  3. 3.

    , & Germinal-center organization and cellular dynamics. Immunity 27, 190–202 (2007).

  4. 4.

    & Germinal centers. Annu. Rev. Immunol. 30, 429–457 (2012).

  5. 5.

    et al. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12, 881–922 (1994).

  6. 6.

    & TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145–173 (1989).

  7. 7.

    , , & Differentiation-specific expression of a novel G protein-coupled receptor from Burkitt's lymphoma. Eur. J. Immunol. 22, 2795–2799 (1992).

  8. 8.

    et al. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87, 1037–1047 (1996).

  9. 9.

    , , , & In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines. J. Exp. Med. 190, 1123–1134 (1999).

  10. 10.

    et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J. Exp. Med. 192, 1545–1552 (2000).

  11. 11.

    et al. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J. Exp. Med. 192, 1553–1562 (2000).

  12. 12.

    et al. Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells. J. Exp. Med. 193, 1373–1381 (2001).

  13. 13.

    , & Separable effector T cell populations specialized for B cell help or tissue inflammation. Nat. Immunol. 2, 876–881 (2001).

  14. 14.

    et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J. Immunol. 173, 68–78 (2004).

  15. 15.

    , , , & Follicular B helper T cell activity is confined to CXCR5(hi)ICOS(hi) CD4 T cells and is independent of CD57 expression. Eur. J. Immunol. 36, 1892–1903 (2006).

  16. 16.

    et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435, 452–458 (2005).

  17. 17.

    et al. Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J. Immunol. 179, 8180–8190 (2007).

  18. 18.

    , , & Human tonsil B-cell lymphoma 6 (BCL6)-expressing CD4+ T-cell subset specialized for B-cell help outside germinal centers. Proc. Natl. Acad. Sci. USA 108, E488–E497 (2011).

  19. 19.

    et al. Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. J. Immunol. 155, 556–567 (1995).

  20. 20.

    , & A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex. J. Exp. Med. 181, 1293–1301 (1995).

  21. 21.

    et al. Bcl6 mediates the development of T follicular helper cells. Science 325, 1001–1005 (2009).

  22. 22.

    et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325, 1006–1010 (2009).

  23. 23.

    et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 31, 457–468 (2009).

  24. 24.

    , , & The good, the bad and the ugly—TFH cells in human health and disease. Nat. Rev. Immunol. 13, 412–426 (2013).

  25. 25.

    Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29, 621–663 (2011).

  26. 26.

    , , , & CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. J. Exp. Med. 188, 297–304 (1998).

  27. 27.

    et al. Germinal center B cell and T follicular helper cell development initiates in the interfollicular zone. Immunity 34, 947–960 (2011).

  28. 28.

    et al. Bcl6 protein expression shapes pre-germinal center B cell dynamics and follicular helper T cell heterogeneity. Immunity 34, 961–972 (2011).

  29. 29.

    et al. Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development. Nature 507, 513–518 (2014).

  30. 30.

    et al. Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation. J. Immunol. 179, 5099–5108 (2007).

  31. 31.

    et al. ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity. J. Exp. Med. 205, 2873–2886 (2008).

  32. 32.

    et al. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 281, 96–99 (1998).

  33. 33.

    et al. B cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cells. J. Exp. Med. 208, 1377–1388 (2011).

  34. 34.

    & T-cell subsets in the germinal center. Immunol. Rev. 252, 146–155 (2013).

  35. 35.

    et al. The development and fate of follicular helper T cells defined by an IL-21 reporter mouse. Nat. Immunol. 13, 491–498 (2012).

  36. 36.

    et al. T follicular helper cell dynamics in germinal centers. Science 341, 673–677 (2013).

  37. 37.

    et al. Sphingosine-1-phosphate receptor 2 is critical for follicular helper T cell retention in germinal centers. J. Exp. Med. 211, 1297–1305 (2014).

  38. 38.

    et al. Dynamic signaling by T follicular helper cells during germinal center B cell selection. Science 345, 1058–1062 (2014).

  39. 39.

    et al. Regulation of the germinal center reaction by Foxp3+ follicular regulatory T cells. J. Immunol. 187, 4553–4560 (2011).

  40. 40.

    et al. Foxp3+ follicular regulatory T cells control the germinal center response. Nat. Med. 17, 975–982 (2011).

  41. 41.

    et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat. Med. 17, 983–988 (2011).

  42. 42.

    , & Leu 7+ (HNK-1+) cells. I. Selective compartmentalization of Leu 7+ cells with different immunophenotypes in lymphatic tissues and blood. Scand. J. Immunol. 18, 485–493 (1983).

  43. 43.

    , , & Functional analysis of cloned germinal center CD4+ cells with natural killer cell-related features. Divergence from typical T helper cells. J. Immunol. 137, 2808–2813 (1986).

  44. 44.

    et al. Early commitment of naive human CD4(+) T cells to the T follicular helper (T(FH)) cell lineage is induced by IL-12. Immunol. Cell Biol. 87, 590–600 (2009).

  45. 45.

    , , & The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding. Nat. Immunol. 10, 375–384 (2009).

  46. 46.

    et al. The cytokine TGF-β co-opts signaling via STAT3-STAT4 to promote the differentiation of human TFH cells. Nat. Immunol. 15, 856–865 (2014).

  47. 47.

    et al. Early Th1 cell differentiation is marked by a Tfh cell-like transition. Immunity 35, 919–931 (2011).

  48. 48.

    et al. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat. Immunol. 10, 167–175 (2009).

  49. 49.

    et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 29, 138–149 (2008).

  50. 50.

    et al. Development and characterization of IL-21-producing CD4+ T cells. J. Exp. Med. 205, 1369–1379 (2008).

  51. 51.

    , , & Expression of the G-protein–coupled receptor BLR1 defines mature, recirculating B cells and a subset of T-helper memory cells. Blood 84, 830–840 (1994).

  52. 52.

    , & Cutting edge: induction of follicular homing precedes effector Th cell development. J. Immunol. 167, 6082–6086 (2001).

  53. 53.

    , & Phenotype and functions of memory Tfh cells in human blood. Trends Immunol. 35, 436–442 (2014).

  54. 54.

    et al. Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination. Sci. Transl. Med. 5, 176ra132 (2013).

  55. 55.

    et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34, 108–121 (2011).

  56. 56.

    et al. CXCR5 expressing human central memory CD4 T cells and their relevance for humoral immune responses. J. Immunol. 186, 5556–5568 (2011).

  57. 57.

    et al. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum. 62, 234–244 (2010).

  58. 58.

    et al. Circulating precursor CCR7(lo)PD-1(hi) CXCR5(+) CD4(+) T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity 39, 770–781 (2013).

  59. 59.

    et al. Human circulating PD-1(+)CXCR3(−)CXCR5(+) memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 39, 758–769 (2013).

  60. 60.

    et al. Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection. PLoS Pathog. 10, e1003853 (2014).

  61. 61.

    et al. Unique gene expression program of human germinal center T helper cells. Blood 104, 1952–1960 (2004).

  62. 62.

    & Discovery of single-gene inborn errors of immunity by next generation sequencing. Curr. Opin. Immunol. 30, 17–23 (2014).

  63. 63.

    et al. ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells. J. Immunol. 177, 4927–4932 (2006).

  64. 64.

    et al. The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo. J. Immunol. 175, 2340–2348 (2005).

  65. 65.

    et al. Importance of B cell co-stimulation in CD4(+) T cell differentiation: X-linked agammaglobulinaemia, a human model. Clin. Exp. Immunol. 164, 381–387 (2011).

  66. 66.

    , , & Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features. Immunol. Rev. 203, 48–66 (2005).

  67. 67.

    et al. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1, 167–178 (1994).

  68. 68.

    , , , & SAP is required for generating long-term humoral immunity. Nature 421, 282–287 (2003).

  69. 69.

    , , , & SAP-controlled T-B cell interactions underlie germinal centre formation. Nature 455, 764–769 (2008).

  70. 70.

    , & SLAM family receptors and SAP adaptors in immunity. Annu. Rev. Immunol. 29, 665–705 (2011).

  71. 71.

    et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 29, 497–510 (2008).

  72. 72.

    et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis. Blood 90, 1458–1470 (1997).

  73. 73.

    et al. Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytes. J. Immunol. 161, 2223–2231 (1998).

  74. 74.

    et al. IL-12 receptor beta1 deficiency alters in vivo T follicular helper cell response in humans. Blood 121, 3375–3385 (2013).

  75. 75.

    et al. Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12. Immunity 31, 158–169 (2009).

  76. 76.

    et al. Functional STAT3 deficiency compromises the generation of human T follicular helper cells. Blood 119, 3997–4008 (2012).

  77. 77.

    , , , & Blood CD4+CD45RO+CXCR5+ T cells are decreased but partially functional in signal transducer and activator of transcription 3 deficiency. J. Allergy Clin. Immunol. 131, 1146–1156, e1141–e1145 (2013).

  78. 78.

    et al. B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J. Exp. Med. 207, 155–171, S151–S155 (2010).

  79. 79.

    & Regulation of autoreactive antibodies. Curr. Opin. Rheumatol. 19, 421–426 (2007).

  80. 80.

    et al. Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface. J. Clin. Invest. 122, 3781–3790 (2012).

  81. 81.

    , & Dysregulation of germinal centres in autoimmune disease. Nat. Rev. Immunol. 9, 845–857 (2009).

  82. 82.

    et al. Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity. Proc. Natl. Acad. Sci. USA 111, E2567–E2575 (2014).

  83. 83.

    et al. Anti-islet autoantibodies trigger autoimmune diabetes in the presence of an increased frequency of islet-reactive CD4 T cells. Diabetes 60, 2102–2111 (2011).

  84. 84.

    et al. Interferon-gamma excess leads to pathogenic accumulation of follicular helper T cells and germinal centers. Immunity 37, 880–892 (2012).

  85. 85.

    et al. Roquin promotes constitutive mRNA decay via a conserved class of stem-loop recognition motifs. Cell 153, 869–881 (2013).

  86. 86.

    et al. Roquin-2 shares functions with its paralog Roquin-1 in the repression of mRNAs controlling T follicular helper cells and systemic inflammation. Immunity 38, 669–680 (2013).

  87. 87.

    et al. Roquin paralogs 1 and 2 redundantly repress the Icos and Ox40 costimulator mRNAs and control follicular helper T cell differentiation. Immunity 38, 655–668 (2013).

  88. 88.

    et al. Follicular helper T cells are required for systemic autoimmunity. J. Exp. Med. 206, 561–576 (2009).

  89. 89.

    et al. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature 450, 299–303 (2007).

  90. 90.

    et al. A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice. Proc. Natl. Acad. Sci. USA 106, 1518–1523 (2009).

  91. 91.

    et al. Roquin differentiates the specialized functions of duplicated T cell costimulatory receptor genes CD28 and ICOS. Immunity 30, 228–241 (2009).

  92. 92.

    et al. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new “speed congenic” stock of NOD.Ig mu null mice. J. Exp. Med. 184, 2049–2053 (1996).

  93. 93.

    et al. Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice. Int. Immunol. 9, 1159–1164 (1997).

  94. 94.

    et al. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes 46, 941–946 (1997).

  95. 95.

    et al. Activating Fc gamma receptors participate in the development of autoimmune diabetes in NOD mice. J. Immunol. 179, 764–774 (2007).

  96. 96.

    et al. Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance. J. Clin. Invest. 117, 1361–1369 (2007).

  97. 97.

    et al. A subset of interleukin-21+ chemokine receptor CCR9+ T helper cells target accessory organs of the digestive system in autoimmunity. Immunity 34, 602–615 (2011).

  98. 98.

    et al. Increased frequency of pre-germinal center b cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J. Immunol. 167, 2361–2369 (2001).

  99. 99.

    et al. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 48, 1332–1342 (2003).

  100. 100.

    et al. Persistent expression of autoantibodies in SLE patients in remission. J. Exp. Med. 203, 2255–2261 (2006).

  101. 101.

    et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med. 201, 703–711 (2005).

  102. 102.

    et al. Role of the frequency of blood CD4(+) CXCR5(+) CCR6(+) T cells in autoimmunity in patients with Sjogren's syndrome. Biochem. Biophys. Res. Commun. 422, 238–244 (2012).

  103. 103.

    et al. Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis. J. Neuroimmunol. 256, 55–61 (2013).

  104. 104.

    et al. High frequencies of activated B cells and T follicular helper cells are correlated with disease activity in patients with new-onset rheumatoid arthritis. Clin. Exp. Immunol. 174, 212–220 (2013).

  105. 105.

    et al. A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis. Arthritis Res. Ther. 14, R255 (2012).

  106. 106.

    et al. Increased frequency of follicular helper T cells in patients with autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 97, 943–950 (2012).

  107. 107.

    et al. Inhibition of increased circulating Tfh cell by anti-CD20 monoclonal antibody in patients with type 1 diabetes. PLoS ONE 8, e79858 (2013).

  108. 108.

    et al. Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis. J. Neuroimmunol. 256, 55–61 (2013).

  109. 109.

    et al. Circulating TFH subset distribution is strongly affected in lupus patients with an active disease. PLoS ONE 8, e75319 (2013).

  110. 110.

    et al. Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression. PLoS ONE 8, e57820 (2013).

  111. 111.

    et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358, 676–688 (2008).

  112. 112.

    et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130, 1089–1104 (2007).

  113. 113.

    , , & Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat. Rev. Immunol. 14, 447–462 (2014).

  114. 114.

    et al. Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue. Sci. Transl. Med. 6, 230ra246 (2014).

  115. 115.

    et al. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity 35, 986–996 (2011).

  116. 116.

    et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32, 815–827 (2010).

  117. 117.

    , , & Requirements for follicular exclusion and competitive elimination of autoantigen-binding B cells. J. Immunol. 172, 4700–4708 (2004).

  118. 118.

    & Coordinating GWAS results with gene expression in a systems immunologic paradigm in autoimmunity. Curr. Opin. Immunol. 24, 544–551 (2012).

  119. 119.

    et al. IRF8 mutations and human dendritic-cell immunodeficiency. N. Engl. J. Med. 365, 127–138 (2011).

  120. 120.

    et al. IRF5 promotes inflammatory macrophage polarization and TH1–TH17 responses. Nat. Immunol. 12, 231–238 (2011).

  121. 121.

    et al. The transcription factor IRF8 activates integrin-mediated TGF-beta signaling and promotes neuroinflammation. Immunity 40, 187–198 (2014).

  122. 122.

    et al. CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles. Eur. J. Immunol. 29, 1610–1616 (1999).

  123. 123.

    et al. Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers. J. Exp. Med. 190, 1115–1122 (1999).

  124. 124.

    et al. CD4(+)CD3(−) accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells. Immunity 18, 643–654 (2003).

  125. 125.

    , , & PTPN22 controls the germinal center by influencing the numbers and activity of T follicular helper cells. J. Immunol. 192, 1415–1424 (2014).

  126. 126.

    et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376–381 (2014).

  127. 127.

    et al. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science 343, 1246949 (2014).

  128. 128.

    et al. Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes. Science 344, 519–523 (2014).

  129. 129.

    et al. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J. Clin. Oncol. 31, 240–246 (2013).

  130. 130.

    , & Advances in the understanding and management of angioimmunoblastic T-cell lymphoma. Br. J. Haematol. 148, 673–689 (2010).

  131. 131.

    et al. Heterozygosity for Roquinsan leads to angioimmunoblastic T-cell lymphoma-like tumors in mice. Blood 120, 812–821 (2012).

  132. 132.

    et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat. Genet. 46, 171–175 (2014).

  133. 133.

    et al. A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood 123, 1293–1296 (2014).

  134. 134.

    et al. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma. Nat. Genet. 46, 371–375 (2014).

  135. 135.

    et al. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood 120, 1466–1469 (2012).

  136. 136.

    , & Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma. Am. J. Surg. Pathol. 36, 109–116 (2012).

  137. 137.

    et al. Follicular center helper T-cell (TFH) marker positive mycosis fungoides/Sezary syndrome. Mod. Pathol. 26, 32–43 (2013).

  138. 138.

    et al. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers. Am. J. Surg. Pathol. 33, 81–90 (2009).

  139. 139.

    , , , & Expression of follicular helper T-cell markers in primary cutaneous T-cell lymphoma. Am. J. Dermatopathol. 36, 465–470 (2014).

  140. 140.

    et al. Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome. J. Clin. Oncol. 24, 5052–5059 (2006).

  141. 141.

    , & Lymphoid malignancies: the dark side of B-cell differentiation. Nat. Rev. Immunol. 2, 920–932 (2002).

  142. 142.

    et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N. Engl. J. Med. 351, 2159–2169 (2004).

  143. 143.

    et al. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J. Clin. Oncol. 25, 390–398 (2007).

  144. 144.

    et al. Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis. Leukemia 24, 2080–2089 (2010).

  145. 145.

    et al. Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment. J. Immunol. 190, 6681–6693 (2013).

  146. 146.

    et al. Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells. Leukemia 26, 1053–1063 (2012).

  147. 147.

    et al. High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 108, 2957–2964 (2006).

  148. 148.

    et al. The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation. Blood 115, 289–295 (2010).

  149. 149.

    , , , & Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma. Cancer Res. 66, 10145–10152 (2006).

  150. 150.

    et al. Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia. Br. J. Haematol. 162, 360–370 (2013).

  151. 151.

    et al. Association of peripheral CD4+ CXCR5+ T cells with chronic lymphocytic leukemia. Tumour Biol. 34, 3579–3585 (2013).

  152. 152.

    et al. IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells. Blood 122, 3010–3019 (2013).

  153. 153.

    et al. CD4(+) follicular helper T cell infiltration predicts breast cancer survival. J. Clin. Invest. 123, 2873–2892 (2013).

  154. 154.

    et al. Circulating follicular helper T cells in Crohn's disease (CD) and CD-associated colorectal cancer. Tumour Biol. 35, 9355–9359 (2014).

  155. 155.

    et al. Dysregulation of circulating follicular helper T cells in nonsmall cell lung cancer. DNA Cell Biol. 33, 355–360 (2014).

  156. 156.

    et al. Thymic TFH cells involved in the pathogenesis of myasthenia gravis with thymoma. Exp. Neurol. 254, 200–205 (2014).

  157. 157.

    et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39, 782–795 (2013).

  158. 158.

    et al. CD4 T follicular helper cell dynamics during SIV infection. J. Clin. Invest. 122, 3281–3294 (2012).

  159. 159.

    , , , & Spatial alterations between CD4(+) T follicular helper, B, and CD8(+) T cells during simian immunodeficiency virus infection: T/B cell homeostasis, activation, and potential mechanism for viral escape. J. Immunol. 188, 3247–3256 (2012).

  160. 160.

    et al. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J. Exp. Med. 210, 143–156 (2013).

  161. 161.

    et al. Expansion of HIV-specific T follicular helper cells in chronic HIV infection. J. Clin. Invest. 122, 3271–3280 (2012).

  162. 162.

    et al. Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nat. Med. 19, 494–499 (2013).

  163. 163.

    et al. Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1. J. Virol. 82, 5548–5561 (2008).

  164. 164.

    , , , & Are follicular dendritic cells, macrophages and interdigitating cells of the lymphoid tissue productively infected by HIV? Res. Virol. 145, 177–182 (1994).

  165. 165.

    Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. Annu. Rev. Immunol. 17, 625–656 (1999).

  166. 166.

    , , , & Highly restricted spread of HIV-1 and multiply infected cells within splenic germinal centers. Proc. Natl. Acad. Sci. USA 97, 14566–14571 (2000).

  167. 167.

    et al. Cellular localization of simian immunodeficiency virus in lymphoid tissues. I. Immunohistochemistry and electron microscopy. Am. J. Pathol. 134, 373–383 (1989).

  168. 168.

    , , & Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection. Science 334, 825–829 (2011).

  169. 169.

    HIV and T follicular helper cells: a dangerous relationship. J. Clin. Invest. 122, 3059–3062 (2012).

  170. 170.

    & B cells in HIV infection and disease. Nat. Rev. Immunol. 9, 235–245 (2009).

  171. 171.

    et al. Follicular helper T cells are required for systemic autoimmunity. J. Exp. Med. 206, 561–576 (2009).

  172. 172.

    et al. Structural insights on the role of antibodies in HIV-1 vaccine and therapy. Cell 156, 633–648 (2014).

  173. 173.

    All eyes on the next generation of HIV vaccines: strategies for inducing a broadly neutralizing antibody response. Discov. Med. 17, 187–199 (2014).

  174. 174.

    et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N. Engl. J. Med. 366, 1275–1286 (2012).

  175. 175.

    et al. Human circulating PD-(+)1CXCR3(−)CXCR5(+) memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 39, 758–769 (2013).

  176. 176.

    et al. Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter. Cell 143, 592–605 (2010).

Download references

Acknowledgements

Supported by the US National Institutes of Health (U19-AI057234, U19-AI082715 and U19-AI089987), the Alliance for Lupus Research, the Baylor Health Care System (H.U.) and the Australian National Health and Medical Research Council (C.G.V.).

Author information

Affiliations

  1. Baylor Institute for Immunology Research, Dallas, Texas, USA.

    • Hideki Ueno
  2. Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA, and Vaccine Research Institute, INSERM U955, Hopital Henri Mondor, Creteil, France.

    • Jacques Banchereau
  3. Department of Pathogens and Immunity, John Curtin School of Medical Research, Australian National University, Canberra, Australia.

    • Carola G Vinuesa

Authors

  1. Search for Hideki Ueno in:

  2. Search for Jacques Banchereau in:

  3. Search for Carola G Vinuesa in:

Competing interests

The authors declare no competing financial interests.

Corresponding authors

Correspondence to Hideki Ueno or Jacques Banchereau or Carola G Vinuesa.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/ni.3054

Further reading